SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001144204-18-059911
Filing Date
2018-11-14
Accepted
2018-11-14 16:01:41
Documents
49
Period of Report
2018-09-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q tv506420_10q.htm 10-Q 498831
2 EXHIBIT 31.1 tv506420_ex31-1.htm EX-31.1 9281
3 EXHIBIT 32.1 tv506420_ex32-1.htm EX-32.1 5866
  Complete submission text file 0001144204-18-059911.txt   4542286

Data Files

Seq Description Document Type Size
4 XBRL INSTANCE DOCUMENT rgrx-20180930.xml EX-101.INS 1340352
5 XBRL TAXONOMY EXTENSION SCHEMA rgrx-20180930.xsd EX-101.SCH 31041
6 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE rgrx-20180930_cal.xml EX-101.CAL 20706
7 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE rgrx-20180930_def.xml EX-101.DEF 194305
8 XBRL TAXONOMY EXTENSION LABEL LINKBASE rgrx-20180930_lab.xml EX-101.LAB 219443
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE rgrx-20180930_pre.xml EX-101.PRE 221960
Mailing Address 15245 SHADY GROVE ROAD SUITE 470 ROCKVILLE MD 20850
Business Address 15245 SHADY GROVE ROAD SUITE 470 ROCKVILLE MD 20850 301-208-9191
REGENERX BIOPHARMACEUTICALS INC (Filer) CIK: 0000707511 (see all company filings)

IRS No.: 521253406 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-15070 | Film No.: 181183489
SIC: 2834 Pharmaceutical Preparations
Assistant Director 1